Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McGill University

$27,000.00

Exploring the role of pathogenicity islands in Mycobacterium avium paratuberculosis virulence

FY 2025-26

Summary
Mycobacterium avium paratuberculosis (MAP) is a pathogenic bacterium that causes Johne’s disease, a chronic intestinal illness in cattle and other ruminants that burdens the agricultural industry. Overlapping symptoms with Crohn’s disease, a human gastrointestinal disorder, suggest MAP may also contribute to human illness, though this connection remains unproven. A genomic feature of MAP that distinguishes it from other closely related bacteria is a DNA region called large sequence polymorphism 12 (LSP12), acquired through DNA exchange between bacterial cells. LSP12 encodes a set of genes (i.e., operon) predicted to help MAP enter and survive in mammalian cells called mammalian cell entry 5 (mce5), along with fat metabolism genes. In other mycobacteria, mce operons are predicted to promote bacterial interactions with fats and contribute to their ability to cause disease (i.e., virulence). Preliminary data from our lab show that MAP lacking LSP12 (and therefore mce5) does not survive as well in animal models, suggesting a role in virulence for LSP12 and mce5. We predict that MAP’s mce operons, including but not limited to mce5, assist with the intake of fat-based nutrients and release of damaging molecules that enhance MAP infection. To test this, we will compare MAP that is missing mce operons to non-mutant MAP by studying their growth on various fat sources, morphology, and ability to infect macrophages (MAP’s host cell) and mice. The results will clarify the extent to which LSP12 and mce operons contribute to MAP virulence. Because humans do not have mce operons, these bacterial proteins may be safe and specific targets for future antimicrobial therapies, particularly relevant if MAP contributes to Crohn’s disease.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572751
Name
Fraser Devin R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the role of pathogenicity islands in Mycobacterium avium paratuberculosis virulence
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Crohn'S Disease; Large Sequence Polymorphism; Lipid Transport; M. Avium Paratuberculosis; Mammalian Cell Entry; Map; Mycobacterial Pathogenesis; Operon; Pathogenicity Island; Virulence
Abstract
Mycobacterium avium paratuberculosis (MAP) is a pathogenic bacterium that causes Johne’s disease, a chronic intestinal illness in cattle and other ruminants that burdens the agricultural industry. Overlapping symptoms with Crohn’s disease, a human gastrointestinal disorder, suggest MAP may also contribute to human illness, though this connection remains unproven. A genomic feature of MAP that distinguishes it from other closely related bacteria is a DNA region called large sequence polymorphism 12 (LSP12), acquired through DNA exchange between bacterial cells. LSP12 encodes a set of genes (i.e., operon) predicted to help MAP enter and survive in mammalian cells called mammalian cell entry 5 (mce5), along with fat metabolism genes. In other mycobacteria, mce operons are predicted to promote bacterial interactions with fats and contribute to their ability to cause disease (i.e., virulence). Preliminary data from our lab show that MAP lacking LSP12 (and therefore mce5) does not survive as well in animal models, suggesting a role in virulence for LSP12 and mce5. We predict that MAP’s mce operons, including but not limited to mce5, assist with the intake of fat-based nutrients and release of damaging molecules that enhance MAP infection. To test this, we will compare MAP that is missing mce operons to non-mutant MAP by studying their growth on various fat sources, morphology, and ability to infect macrophages (MAP’s host cell) and mice. The results will clarify the extent to which LSP12 and mce operons contribute to MAP virulence. Because humans do not have mce operons, these bacterial proteins may be safe and specific targets for future antimicrobial therapies, particularly relevant if MAP contributes to Crohn’s disease.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fraser, Devin R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~